Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels

被引:26
作者
Sata, M
Walsh, K
机构
[1] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02135 USA
[2] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[3] Tufts Univ, Sackler Sch Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA
关键词
D O I
10.1006/jmcc.2000.1176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fas ligand (FasL) is a death factor that induces apoptosis in Fas-bearing cells. To explore the role of Fast in vascular lesion formation, we analysed leukocyte infiltration and lesion formation in a flow-restriction model of vascular injury that results in neointima formation in the presence of intact endothelium. The left common carotid arteries of wild-type and FasL-deficient (gld) mice were ligated just proximal to the carotid bifurcation. Three days after the ligation, T lymphocyte and macrophage infiltration into the common carotid artery was notably enhanced in the gld mice relative to the wild-type C57BL/6J mice. Four weeks after the ligation, the common carotid arteries developed neointima-like lesions consisting primarily of alpha-smooth muscle actin-positive cells beneath an endothelial cell monolayer. Neointima formation was greater in the gld mice than in wild-type mice. These data provide mouse genetic evidence suggesting that Fas-mediated cell death can function to restrict inflammation and intimal hyperplasia during vascular remodelling. (C) 2000 Academic Press.
引用
收藏
页码:1395 / 1400
页数:6
相关论文
共 27 条
[1]   FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[2]   SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS [J].
ANDREWS, BS ;
EISENBERG, RA ;
THEOFILOPOULOS, AN ;
IZUI, S ;
WILSON, CB ;
MCCONAHEY, PJ ;
MURPHY, ED ;
ROTHS, JB ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) :1198-1215
[3]   The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions [J].
Cai, WJ ;
Devaux, B ;
Schaper, W ;
Schaper, J .
ATHEROSCLEROSIS, 1997, 131 (02) :177-186
[4]  
Carmeliet P, 1997, AM J PATHOL, V150, P761
[5]  
Dong CM, 1996, LAB INVEST, V74, P921
[6]  
Fukuo K, 1997, GERONTOLOGY, V43, P35
[7]   Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells [J].
Geng, YJ ;
Henderson, LE ;
Levesque, EB ;
Muszynski, M ;
Libby, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :2200-2208
[8]   Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages [J].
Kiener, PA ;
Davis, PM ;
Starling, GC ;
Mehlin, C ;
Klebanoff, SJ ;
Ledbetter, JA ;
Liles, WC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (08) :1511-1516
[9]   ACTIVATION INTERFERES WITH THE APO-1 PATHWAY IN MATURE HUMAN T-CELLS [J].
KLAS, C ;
DEBATIN, KM ;
JONKER, RR ;
KRAMMER, PH .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) :625-630
[10]  
Kumar A, 1997, CIRCULATION, V96, P4333